OTCMKTS:SZLSF

StageZero Life Sciences (SZLSF) Stock Forecast, Price & News

$0.03

-0.02 (-40.00%)

(As of 06/7/2023 ET)

Compare

Today's Range: $0.03
▼
$0.04
50-Day Range: $0.03
▼
$0.08
52-Week Range: $0.03
▼
$0.10

Volume: 3,575 shs
Average Volume: 1,184 shs
Market Capitalization: $3.16 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Profile Chart Competitors Earnings Financials Headlines SEC Filings Short Interest

About StageZero Life Sciences (OTCMKTS:SZLSF) Stock

StageZero Life Sciences Ltd. engages in the development and commercialization of proprietary molecular diagnostic tests for detection of diseases and for personalized health management, with a focus on cancer-related indications. Its products includes Sentinel Principle, and ColonSentry. The company was founded by Choong-Chin Liew and K. Wayne Marshall on February 20, 1997 and is headquartered in Richmond Hill, Canada.

Receive SZLSF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for StageZero Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

SZLSF Stock News Headlines

June 7, 2023 | finance.yahoo.com

StageZero Life Sciences, Ltd Announces Results of Resolutions at Annual and Special Meeting

May 17, 2023 | theglobeandmail.com

Dually-Listed Healthcare Stock Rallies On Q1 Results

June 8, 2023 | Behind the Markets (Ad)

The 4th Military Revolution is Happening

. There have been 3 military revolutions in the past 100 years. The first was when the tank was invented in 1915. The second was the nuclear bomb in 1945. The third was the "smart bomb" in 1991. Amid the turmoil, there will be many losers. Click here to see how to win instead >>>

May 15, 2023 | finance.yahoo.com

StageZero to Issue Q1 2023 Financial Results After Market Closes May 15, 2023

April 4, 2023 | msn.com

Stagezero Life Sciences GAAP EPS of -$0.09, revenue of $0.7M

March 30, 2023 | finance.yahoo.com

StageZero to Issue Q4 2022 Financial Results on Friday March 31

March 29, 2023 | finance.yahoo.com

StageZero to Issue Q4 2022 Financial Results and Hold Conference Call on Thursday March 30

February 15, 2023 | finance.yahoo.com

Results from METRICs Study Informs Expansion of StageZero's New Care Oncology Protocol

June 8, 2023 | Behind the Markets (Ad)

[BREAKING] New "Living Software" to Revolutionize Warfare

This breakthrough will change "the way wars will be fought, and won, for years to come." - Chairman of the Joint Chief of Staff, General Mark Milley Get the name of the company supplying it to the U.S. Army here >>>

January 12, 2023 | finanznachrichten.de

StageZero Life Sciences Ltd: StageZero Life Sciences Announces Extension of Warrants Expiring in January 2023

January 12, 2023 | finance.yahoo.com

StageZero Life Sciences Announces Extension of Warrants Expiring in January 2023

November 15, 2022 | seekingalpha.com

StageZero Life Sciences Ltd. (SZLSF) Q3 2022 Earnings Call Transcript

November 12, 2022 | finance.yahoo.com

StageZero to Hold Q3 2022 Operational and Financial Results Conference Call on Tuesday November 15, 2022

August 19, 2022 | finanznachrichten.de

StageZero Life Sciences Ltd: StageZero Announces Solutions for Employers to Help Improve Cancer Outcomes

August 12, 2022 | finance.yahoo.com

StageZero to Hold Q2 2022 Operational and Financial Results Conference Call on Tuesday August 16, 2022

May 26, 2022 | seekingalpha.com

StageZero Life Sciences CFO resigns

May 25, 2022 | finance.yahoo.com

StageZero Life Sciences Partners with DiagnoseAtHome to Offer Aristotle(R) Multi-Cancer Blood Test in Canada and USA

May 17, 2022 | finanznachrichten.de

StageZero Life Sciences Ltd: StageZero Life Sciences, Ltd Announces Q1 2022 Financial Results and Operational Update

May 17, 2022 | finance.yahoo.com

StageZero Life Sciences, Ltd Announces Q1 2022 Financial Results and Operational Update

April 6, 2022 | finance.yahoo.com

StageZero Life Sciences, Ltd Announces Corporate Update

April 1, 2022 | finance.yahoo.com

StageZero Life Sciences, Ltd Announces Q4 2021 and Year End Financial Results and Operational Update

March 31, 2022 | finanznachrichten.de

StageZero Life Sciences Ltd: StageZero Life Sciences Launches AVRT in the UK

March 31, 2022 | finance.yahoo.com

StageZero Life Sciences Launches AVRT(TM) in the UK

March 14, 2022 | finanznachrichten.de

StageZero Life Sciences Ltd: CORRECTING AND REPLACING: StageZero Life Sciences Announces Availability of COC Protocol in Europe

March 14, 2022 | lse.co.uk

CQN:StageZero Announces COC Protocol in Europe

March 14, 2022 | finanznachrichten.de

StageZero Life Sciences Ltd: StageZero Life Sciences Announces Availability of COC Protocol in Europe

March 14, 2022 | finance.yahoo.com

StageZero Life Sciences Announces Availability of COC Protocol in Europe

See More Headlines

SZLSF Price History

30 days | 90 days | 365 days | Advanced Chart

SZLSF Company Calendar

Last Earnings: 3/31/2023
Today: 6/08/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Diagnostic substances
Sub-Industry: N/A
Sector: Medical
Current Symbol: OTCMKTS:SZLSF
CUSIP: N/A
CIK: 1454263
Web: www.stagezerolifesciences.com
Phone: (855) 420-7140
Fax: 905-209-2031
Employees: 51
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($0.12)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-11,410,000.00
Net Margins: -388.59%
Pretax Margin: -91.19%
Return on Equity: -877.87%
Return on Assets: -148.07%

Debt

Debt-to-Equity Ratio: 0.44
Current Ratio: 0.08
Quick Ratio: 0.04

Sales & Book Value

Annual Sales: $3.80 million
Price / Sales: 0.83
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $0.03 per share
Price / Book: 1.00

Miscellaneous

Outstanding Shares: 105,460,000
Free Float: 102,786,000
Market Cap: $3.16 million
Optionable: Not Optionable
Beta: 0.57

Key Executives

James R. Howard-Tripp
Executive Chairman & Chief Executive Officer

Rebecca Greco
Head-Investor Relations

Key Competitors

View All Competitors

SZLSF Stock - Frequently Asked Questions

How have SZLSF shares performed in 2023?: StageZero Life Sciences' stock was trading at $0.0443 on January 1st, 2023. Since then, SZLSF shares have decreased by 32.3% and is now trading at $0.03.
View the best growth stocks for 2023 here.
How were StageZero Life Sciences' earnings last quarter?: StageZero Life Sciences Ltd. (OTCMKTS:SZLSF) posted its earnings results on Friday, March, 31st. The company reported ($0.09) EPS for the quarter. The business earned $0.68 million during the quarter. StageZero Life Sciences had a negative net margin of 388.59% and a negative trailing twelve-month return on equity of 877.87%.
What is StageZero Life Sciences' stock symbol?: StageZero Life Sciences trades on the OTCMKTS under the ticker symbol "SZLSF."

How do I buy shares of StageZero Life Sciences?: Shares of SZLSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is StageZero Life Sciences' stock price today?: One share of SZLSF stock can currently be purchased for approximately $0.03.
How much money does StageZero Life Sciences make?: StageZero Life Sciences (OTCMKTS:SZLSF) has a market capitalization of $3.16 million and generates $3.80 million in revenue each year. The company earns $-11,410,000.00 in net income (profit) each year or ($0.12) on an earnings per share basis.
How can I contact StageZero Life Sciences?: StageZero Life Sciences' mailing address is 70 East Beaver Creek Road Unit 30, Richmond Hill A6, L4B 3B2. The official website for the company is www.stagezerolifesciences.com. The company can be reached via phone at (855) 420-7140, via email at rgreco@stagezerols.com, or via fax at 905-209-2031.

This page (OTCMKTS:SZLSF) was last updated on 6/8/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial